Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness

• The CEO of Novartis, with a medical background, emphasizes the importance of focusing on breakthrough innovations and patient impact in leading the company
• Implemented changes to focus on innovative medicines by spinning off non-core businesses, leading to unlocking significant value for the company
• Novartis structures R&D differently by having a strategy and growth function, focusing on key therapeutic areas, and investing in advanced technology platforms like radio ligand therapies and cell and gene therapies

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.